Advanced BioMedical Technologies, Inc.
ABMT
$0.0003
$0.000150.00%
| 07/31/2021 | 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | |
|---|---|---|---|---|---|
| Net Income | -5.08% | -9.94% | 11.02% | 5.80% | 2.15% |
| Total Depreciation and Amortization | -46.77% | -21.02% | 3.97% | 185.80% | -219.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -73.33% | -48.28% | -81.84% | 16.83% | 272.73% |
| Change in Net Operating Assets | 340.00% | 106.81% | -141.61% | 211.51% | 876.90% |
| Cash from Operations | 45.01% | 71.39% | -168.44% | 641.81% | 165.42% |
| Capital Expenditure | 93.61% | -71.98% | -1,720.00% | 28.57% | 94.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 93.61% | -71.98% | -1,720.00% | 28.57% | 94.95% |
| Total Debt Issued | -50.65% | -50.25% | 418.50% | -32.58% | -142.76% |
| Total Debt Repaid | -227.27% | 94.69% | 95.49% | -4,074.55% | -1.85% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.29% | -16.67% | 14.29% | 22.22% | 18.18% |
| Cash from Financing | -52.65% | -47.63% | 158.60% | -493.77% | -151.91% |
| Foreign Exchange rate Adjustments | 33.33% | -87.23% | -39.74% | 3,800.00% | 300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 140.00% | 98.71% | -203.21% | 4,826.32% | 46.15% |
